Systemic Steroids Accelerate Symptom Resolution in Orbital Cellulitis

Orbital cellulitis remains a high-stakes ocular emergency that requires prompt hospitalization and aggressive intravenous antibiotic therapy to prevent permanent vision loss or intracranial extension [1]. While antibiotics target the underlying pathogen, the secondary inflammatory response often drives the most immediate threats to the optic nerve and ocular motility [2]. To mitigate this damage, some clinicians utilize adjunctive systemic corticosteroids to reduce edema, although concerns persist regarding potential immune suppression and the masking of treatment failure [3]. Current management strategies vary significantly across institutions, reflecting a lack of standardized protocols for these adjunctive agents [4]. A recent evidence-based assessment clarifies the safety profile and clinical utility of this approach, helping practicing physicians weigh the risks and benefits of adding steroids to acute treatment regimens.